Solving the World's Most Challenging Hearing Disorders
The Virginia Merrill Bloedel Hearing Research Center drives breakthroughs in hair cell regeneration, cochlear implants, and balance restoration — bringing hope to the 40 million Americans living with hearing loss.
Recent Impact
Donor support accelerates discovery. Here are some of the moments that define our work.
First FDA-Approved Gene Therapy for Genetic Hearing Loss
In April 2026, the FDA approved Otarmeni — the first gene therapy for OTOF-related congenital hearing loss, a condition caused by mutations in the otoferlin gene that leaves children profoundly deaf from birth. VMBHRC researchers including Dr. Rubinstein and Dr. Phillips contributed foundational expertise in cochlear physiology and implant candidacy evaluation that informed how gene therapy candidates were identified and trialed. The approval marks a historic moment: a child born deaf due to a single genetic mutation can now be treated with a targeted biological intervention rather than lifelong device dependence. This breakthrough reflects the power of combining basic research, clinical expertise, and philanthropic investment over years of sustained effort.
Read more →Whitcraft Family Gift Unlocks 5-Year NIH Grant for Stone Lab
When the Whitcraft family made a generous pilot grant to Dr. Jennifer Stone's hair cell regeneration laboratory, they did far more than fund a single set of experiments. The resulting pilot data — showing that a specific molecular pathway could be modulated to extend the window of hair cell regeneration in mammals — formed the scientific core of a successful 5-year R01 application to the National Institutes of Health. For every philanthropic dollar invested, multiple federal dollars followed, dramatically amplifying the impact of the original gift. The Whitcraft family's story illustrates a pattern seen repeatedly at VMBHRC: private philanthropy takes the risks that federal agencies cannot, generating the evidence needed to unlock much larger pools of public research funding.
Read more →Edwin W Rubel Trainee Endowment Campaign Launched
In March 2026, VMBHRC launched a campaign to establish a permanent trainee endowment honoring Dr. Edwin W Rubel, the Chair Emeritus whose decades of leadership built VMBHRC into one of North America's premier hearing research centers. The endowment is designed to bridge funding gaps that postdoctoral researchers and advanced graduate students face during transitions between grants — the periods when brilliant trainees are most at risk of leaving academia. Dr. Rubel's mentorship shaped a generation of hearing scientists now leading labs around the world, and this endowment will extend that legacy permanently. Contributions of all sizes are welcome, with naming recognition available for donors who establish named awards within the fund.
Read more →Seven Paths to Discovery
From hair cell biology to cochlear implant engineering — our research spans the full spectrum of hearing and balance science.
Hair Cell Regeneration
Stone and Raible use zebrafish and mouse models to understand how the ear's delicate sensory hair cells — once destroyed by noise, aging, or drugs — might be coaxed to regrow.
Learn more →Cochlear Implants & Child Development
Horn's Prosthetic Auditory Development Lab, established in 2015 at Seattle Children's, studies how deaf and hard-of-hearing children develop language after receiving cochlear implants.
Learn more →Preventing Drug-Induced Hearing Loss
Aminoglycoside antibiotics such as tobramycin and streptomycin — lifesaving drugs for serious infections — can permanently destroy the very hair cells needed for hearing.
Learn more →Your gift accelerates discovery.
Every dollar funds the science that could restore hearing to millions.
Give Now